Skip to main content
. 2016 May 9;263:1401–1408. doi: 10.1007/s00415-016-8132-1

Table 3.

Clinical summary of participants reporting a diagnosis of FSHD1 in the UK FSHD patient registry

FSHD 1 (n = 463a) Genetically confirmed (n = 298) % of genetically confirmed reporting symptom (%)
Hearing loss
 Yes/no (unknown) 80/345 (38) 54/222 (22) 18.12
Retinal vascular diseaseb
 Yes/no (unknown) 10/371 (65) 9/230 (59) 3.02
Current motor function
 Ambulant 211 143 47.99
 Ambulant with assistance 171 112 37.58
 Non-ambulant 81 43 14.43
Wheelchair use
 Full-time 82 45 15.10
 Part-time 103 65 21.82
 None 278 188 63.09
Facial weakness 347 214 71.81
Scapular weakness 428 270 90.60
Hip girdle weakness 346 214 71.81
Foot drop 341 215 72.15

a12 records excluded for missing or incomplete patient reported data

bAn additional 17 participants did not respond to the question about retinal vascular disease n = 446